Hims & Hers Health (HIMS) EV to EBITDA (2019 - 2026)

Hims & Hers Health has disclosed EV to EBITDA across 8 years of filings, most recently posting 74.57 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 119.71% year-over-year to 74.57; the TTM figure through Jun 2026 stood at 46.9 (down 158.27% YoY), while the FY2025 annual figure was 64.4, down 20.9% from the prior year.
• EV to EBITDA came in at 74.57 for Q2 2026 at Hims & Hers Health, down from 51.56 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 1039.55 in Q3 2025 to a low of 4197.52 in Q4 2023.
• Average EV to EBITDA over 5 years is 92.07, with a median of 42.41 recorded in 2022.
• Year-over-year, EV to EBITDA sank 4112.37% in 2023 and jumped 518.9% in 2025.
• Over 5 years, EV to EBITDA stood at 99.65 in 2022, then slumped by 4112.37% to 4197.52 in 2023, then soared by 106.46% to 271.0 in 2024, then jumped by 173.2% to 740.38 in 2025, then plunged by 110.07% to 74.57 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 74.57 in Q2 2026, 51.56 in Q1 2026, and 740.38 in Q4 2025.